Novel |
GAB1 |
GRB2 associated binding protein 1 |
- PI3K Cascade
- Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants
- PIP3 activates AKT signaling
- GAB1 signalosome
- PI3K events in ERBB2 signaling
- Constitutive Signaling by Aberrant PI3K in Cancer
- Constitutive Signaling by EGFRvIII
- PI-3K cascade:FGFR1
- PI-3K cascade:FGFR2
- PI-3K cascade:FGFR3
- PI-3K cascade:FGFR4
- Signaling by FGFR2 in disease
- Signaling by FGFR4 in disease
- Signaling by FGFR1 in disease
- Signaling by FGFR3 in disease
- PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling
- MET activates PI3K/AKT signaling
- RET signaling
- MET activates PTPN11
- MET activates RAP1 and RAC1
- MET receptor recycling
- Erythropoietin activates Phosphoinositide-3-kinase (PI3K)
- Activated NTRK2 signals through PI3K
- Signaling by ERBB2 KD Mutants
- Signaling by ERBB2 ECD mutants
|
|
|
Novel |
GAB2 |
GRB2 associated binding protein 2 |
- PI3K Cascade
- PIP3 activates AKT signaling
- Signaling by SCF-KIT
- Signaling by cytosolic FGFR1 fusion mutants
- Constitutive Signaling by Aberrant PI3K in Cancer
- Role of LAT2/NTAL/LAB on calcium mobilization
- Role of LAT2/NTAL/LAB on calcium mobilization
- PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling
- RET signaling
- Interleukin-15 signaling
- Interleukin receptor SHC signaling
- FLT3 Signaling
- FLT3 Signaling
- STAT5 Activation
- Signaling by CSF3 (G-CSF)
- Signaling by CSF3 (G-CSF)
- Signaling by CSF1 (M-CSF) in myeloid cells
- STAT5 activation downstream of FLT3 ITD mutants
- Signaling by FLT3 fusion proteins
- Signaling by FLT3 fusion proteins
- Signaling by FLT3 ITD and TKD mutants
- Signaling by FLT3 ITD and TKD mutants
|
|
|
Novel |
GAB3 |
GRB2 associated binding protein 3 |
- Signaling by CSF1 (M-CSF) in myeloid cells
|
|
|
Novel |
GALNT12 |
polypeptide N-acetylgalactosaminyltransferase 12 |
- Defective GALNT12 causes CRCS1
- O-linked glycosylation of mucins
|
|
|
Novel |
GFAP |
glial fibrillary acidic protein |
- Nuclear signaling by ERBB4
- Chaperone Mediated Autophagy
|
|
|
Novel |
GIT1 |
GIT ArfGAP 1 |
- Ephrin signaling
- Ephrin signaling
- CDC42 GTPase cycle
- RAC1 GTPase cycle
- RAC2 GTPase cycle
- RHOQ GTPase cycle
- RHOJ GTPase cycle
- RHOU GTPase cycle
- RAC3 GTPase cycle
- RHOV GTPase cycle
- Activation of RAC1 downstream of NMDARs
|
|
|
Novel |
GJA1 |
gap junction protein alpha 1 |
- Oligomerization of connexins into connexons
- Transport of connexins along the secretory pathway
- Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane
- Gap junction assembly
- Gap junction assembly
- Gap junction degradation
- Regulation of gap junction activity
- Regulation of gap junction activity
- Formation of annular gap junctions
- RHOQ GTPase cycle
- RHOJ GTPase cycle
- SARS-CoV-2 targets PDZ proteins in cell-cell junction
- Mechanical load activates signaling by PIEZO1 and integrins in osteocytes
|
|
- Deafness, autosomal recessive
- Oculodentodigital dysplasia
- Syndactyly
|
Novel |
GJB1 |
gap junction protein beta 1 |
- Oligomerization of connexins into connexons
- Oligomerization of connexins into connexons
- Transport of connexins along the secretory pathway
- Gap junction assembly
|
|
- Charcot-Marie-Tooth disease (CMT); Hereditary motor and sensory neuropathy; Peroneal muscular atrophy
|
Novel |
GRB10 |
growth factor receptor bound protein 10 |
- Signaling by SCF-KIT
- IRS activation
- Signal attenuation
- Insulin receptor signalling cascade
- RET signaling
- FLT3 Signaling
- Response of EIF2AK1 (HRI) to heme deficiency
|
|
|
Novel |
GRB2 |
growth factor receptor bound protein 2 |
- Interleukin-15 signaling
- Interleukin-15 signaling
- Signaling by CSF3 (G-CSF)
- Signaling by CSF3 (G-CSF)
- STAT5 activation downstream of FLT3 ITD mutants
- Signaling by FLT3 ITD and TKD mutants
- Signaling by FLT3 ITD and TKD mutants
- Signaling by ALK fusions and activated point mutants
- Signaling by LTK
|
- Pegademase
- 4-[(10s,14s,18s)-18-(2-Amino-2-Oxoethyl)-14-(1-Naphthylmethyl)-8,17,20-Trioxo-7,16,19-Triazaspiro[5.14]Icos-11-En-10-Yl]Benzylphosphonic Acid
|
|
Novel |
GRIN2A |
glutamate ionotropic receptor NMDA type subunit 2A |
- Unblocking of NMDA receptors, glutamate binding and activation
- Unblocking of NMDA receptors, glutamate binding and activation
- Neurexins and neuroligins
- Synaptic adhesion-like molecules
- MECP2 regulates neuronal receptors and channels
- Assembly and cell surface presentation of NMDA receptors
- Assembly and cell surface presentation of NMDA receptors
- Negative regulation of NMDA receptor-mediated neuronal transmission
- Long-term potentiation
|
- Glutamic acid
- Glycine
- Tramadol
- Enflurane
- Atomoxetine
- Pentobarbital
- Methadone
- Secobarbital
- Meperidine
- Dextropropoxyphene
- Acamprosate
- Donepezil
- Guaifenesin
- Felbamate
- Memantine
- Halothane
- Phenobarbital
- Aripiprazole
- Tenocyclidine
- Prasterone
- Milnacipran
- Acetylcysteine
- Ketobemidone
- Gavestinel
- Magnesium acetate tetrahydrate
- Magnesium carbonate
- Esketamine
- Fluciclovine (18F)
|
|
Novel |
GRIN2B |
glutamate ionotropic receptor NMDA type subunit 2B |
- EPHB-mediated forward signaling
- EPHB-mediated forward signaling
- Unblocking of NMDA receptors, glutamate binding and activation
- Unblocking of NMDA receptors, glutamate binding and activation
- Ras activation upon Ca2+ influx through NMDA receptor
- RAF/MAP kinase cascade
- Neurexins and neuroligins
- Synaptic adhesion-like molecules
- MECP2 regulates neuronal receptors and channels
- Activated NTRK2 signals through FYN
- Assembly and cell surface presentation of NMDA receptors
- Assembly and cell surface presentation of NMDA receptors
- Negative regulation of NMDA receptor-mediated neuronal transmission
- Long-term potentiation
|
- Glutamic acid
- Tramadol
- Enflurane
- Atomoxetine
- Pentobarbital
- Methadone
- Secobarbital
- Meperidine
- Haloperidol
- Dextropropoxyphene
- Acamprosate
- Donepezil
- Guaifenesin
- Felbamate
- Memantine
- Phenobarbital
- Aripiprazole
- Tenocyclidine
- Prasterone
- Taurine
- Milnacipran
- EVT-101
- Lumateperone
- Acetylcysteine
- Ketobemidone
- Gavestinel
- Ifenprodil
- Magnesium acetate tetrahydrate
- Magnesium carbonate
- Esketamine
- Esketamine
- Fluciclovine (18F)
|
|
Novel |
GRK2 |
G protein-coupled receptor kinase 2 |
- Calmodulin induced events
- G alpha (q) signalling events
- G alpha (s) signalling events
- Activation of SMO
- Activation of SMO
- Cargo recognition for clathrin-mediated endocytosis
|
|
|
Novel |
GTF2I |
general transcription factor IIi |
|
|
|
Novel |
GUCY2C |
guanylate cyclase 2C |
- Digestion
- Intestinal infectious diseases
|
|
|
Novel |
HDAC3 |
histone deacetylase 3 |
- p75NTR negatively regulates cell cycle via SC1
- PPARA activates gene expression
- PPARA activates gene expression
- NOTCH1 Intracellular Domain Regulates Transcription
- Transcriptional activation of mitochondrial biogenesis
- Constitutive Signaling by NOTCH1 PEST Domain Mutants
- Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants
- HDACs deacetylate histones
- Notch-HLH transcription pathway
- Transcriptional regulation of white adipocyte differentiation
- Transcriptional regulation of white adipocyte differentiation
- Association of TriC/CCT with target proteins during biosynthesis
- Regulation of lipid metabolism by PPARalpha
- Activation of anterior HOX genes in hindbrain development during early embryogenesis
- RUNX2 regulates osteoblast differentiation
- Regulation of PTEN gene transcription
- Loss of MECP2 binding ability to the NCoR/SMRT complex
- Regulation of MECP2 expression and activity
- NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux
- HCMV Early Events
- STAT3 nuclear events downstream of ALK signaling
- Cytoprotection by HMOX1
- Heme signaling
- Heme signaling
- MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis
- MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis
- Expression of BMAL (ARNTL), CLOCK, and NPAS2
- Expression of BMAL (ARNTL), CLOCK, and NPAS2
- RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression
- RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression
|
- Valproic acid
- Decitabine
- Vorinostat
- Vorinostat
- Belinostat
- Pracinostat
- Romidepsin
- Panobinostat
- Phenylbutyric acid
- Mocetinostat
- Entinostat
- Abexinostat
- Givinostat
- Pyroxamide
|
|
Novel |
HEMGN |
hemogen |
|
|
|
Novel |
HLA-A |
major histocompatibility complex, class I, A |
- ER-Phagosome pathway
- ER-Phagosome pathway
- Endosomal/Vacuolar pathway
- Nef mediated downregulation of MHC class I complex cell surface expression
- Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell
- Interferon gamma signaling
- E3 ubiquitin ligases ubiquitinate target proteins
- Interferon alpha/beta signaling
- SARS-CoV-2 activates/modulates innate and adaptive immune responses
- Antigen Presentation: Folding, assembly and peptide loading of class I MHC
- Antigen Presentation: Folding, assembly and peptide loading of class I MHC
|
- 3-Indolebutyric Acid
- Nelipepimut-S
- Nelipepimut-S
- Coccidioides immitis spherule
- Coccidioides immitis spherule
|
|
Novel |
HLA-B |
major histocompatibility complex, class I, B |
- ER-Phagosome pathway
- ER-Phagosome pathway
- Endosomal/Vacuolar pathway
- Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell
- DAP12 interactions
- Neutrophil degranulation
- Interferon gamma signaling
- Interferon alpha/beta signaling
- SARS-CoV-2 activates/modulates innate and adaptive immune responses
- Antigen Presentation: Folding, assembly and peptide loading of class I MHC
- Antigen Presentation: Folding, assembly and peptide loading of class I MHC
|
- Abacavir
- N-Formylmethionine
- Coccidioides immitis spherule
|
|
Novel |
HNF1A |
HNF1 homeobox A |
- Regulation of gene expression in beta cells
|
|
- Maturity onset diabetes of the young (MODY)
|